- Home
- WAI vs AKTX Comparison
WAI vs AKTX Comparison
Compare WAI & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- AKTX
- Stock Information
- Founded
- WAI 2018
- AKTX N/A
- Country
- WAI China
- AKTX United States
- Employees
- WAI N/A
- AKTX N/A
- Industry
- WAI
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- WAI
- AKTX Health Care
- Exchange
- WAI NYSE
- AKTX Nasdaq
- Market Cap
- WAI 28.2M
- AKTX 29.1M
- IPO Year
- WAI 2023
- AKTX N/A
- Fundamental
- Price
- WAI $2.00
- AKTX $1.28
- Analyst Decision
- WAI
- AKTX
- Analyst Count
- WAI 0
- AKTX 0
- Target Price
- WAI N/A
- AKTX N/A
- AVG Volume (30 Days)
- WAI 78.6K
- AKTX 11.7K
- Earning Date
- WAI 06-17-2025
- AKTX 05-15-2025
- Dividend Yield
- WAI N/A
- AKTX N/A
- EPS Growth
- WAI N/A
- AKTX N/A
- EPS
- WAI N/A
- AKTX N/A
- Revenue
- WAI $3,750,352.00
- AKTX N/A
- Revenue This Year
- WAI N/A
- AKTX N/A
- Revenue Next Year
- WAI N/A
- AKTX N/A
- P/E Ratio
- WAI N/A
- AKTX N/A
- Revenue Growth
- WAI N/A
- AKTX N/A
- 52 Week Low
- WAI $1.60
- AKTX $0.85
- 52 Week High
- WAI $20.00
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- AKTX 47.39
- Support Level
- WAI N/A
- AKTX $1.20
- Resistance Level
- WAI N/A
- AKTX $1.42
- Average True Range (ATR)
- WAI 0.00
- AKTX 0.08
- MACD
- WAI 0.00
- AKTX -0.00
- Stochastic Oscillator
- WAI 0.00
- AKTX 36.99
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).